Plasmid-based transient human stromal cell-derived factor-1 gene transfer improves cardiac function in chronic heart failure.

Gene Ther · 2011 · PMC3169804 · PMID 21472007

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

a strong trendP =0.08so close (0.05 < p ≤ 0.1)

These results exhibit a strong trend toward reduction in cardiac fibrosis following SDF-1 treatment ( P =0.08) ( Figures 4a and b ).

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.